Clinical Trial Update: Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for regional prophylactic vancomycin with restricted tourniquet time in primary total knee replacement (Phase 2/Phase 3) completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthropathy of the Knee
• Knee Arthropathy
• Osteoarthritis of the Knee

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Mayo Clinic | Conditions: Arthropathy of Knee Joint | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-12-17